kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer KRAS G12D: The Next Frontier
KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma The mechanistic overview of vitamin C toxicity in cancer cells with Download Scientific Diagram Uncovering new therapeutic targets for a common KRAS mutation behind cancer
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10


